News

In a groundbreaking study published in the journal Thyroid, researchers from the Endocrine Tumours group at the Germans Trias i Pujol Research Institute (IGTP), in close collaboration with five university hospitals, have mapped the intricate dynamics of DNA methylation in metastatic differentiated thyroid cancer (DTC).

Familial adenomatous polyposis (FAP) stands as one of the most daunting hereditary disorders in the realm of gastrointestinal oncology, characterized primarily by the development of hundreds to thousands of polyps throughout the colon at an early age. Though the threat of colorectal cancer in FAP

A groundbreaking advancement in the application of artificial intelligence to thyroid cancer diagnosis has been unveiled by an interdisciplinary team of researchers from the University of Hong Kong’s LKS Faculty of Medicine (HKUMed), the InnoHK Laboratory of Data Discovery for Health (InnoHK D24H), and the

The National Foundation for Cancer Research (NFCR) proudly announces a landmark moment in the world of oncology education and mentorship. Dr. Robert C. Bast, Jr., a visionary cancer scientist whose work has significantly influenced ovarian cancer diagnosis and treatment, has been honored with the 2025

In a groundbreaking study recently published in The Journal of Immunology, scientists have unveiled a critical molecular link between Plasmodium falciparum malaria infection and the onset of Burkitt lymphoma (BL), a highly aggressive childhood cancer predominantly prevalent in equatorial Africa and New Guinea. While the

In a groundbreaking initiative poised to influence the future of gastric cancer treatment, an international team of researchers has launched a large-scale, multicenter randomized controlled trial investigating the impact of perioperative probiotic supplementation on patients undergoing minimally invasive radical gastrectomy following neoadjuvant chemotherapy (NACT). This

Colorectal cancer (CRC) ranks among the most prevalent and lethal malignancies worldwide, with its complex pathogenesis involving a convergence of genetic, epigenetic, immunological, and environmental factors. As populations age globally, the incidence of CRC continues to rise, underscoring the urgent need to deepen our understanding

In a groundbreaking new study, researchers have shed light on the crucial role of myocyte enhancer factor 2 (MEF2) family members—specifically MEF2A, MEF2C, and MEF2D—in the pathogenesis and prognosis of pancreatic adenocarcinoma (PAAD). Pancreatic cancer remains one of the deadliest malignancies worldwide due to its

Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are unveiling groundbreaking advancements in cancer research at the prestigious American Association for Cancer Research (AACR) Annual Meeting in Chicago from

BETHESDA, MD – In a groundbreaking 20-year study conducted by the Kaiser Permanente Division of Research in Northern California, researchers have demonstrated that equitable, flexible colorectal cancer (CRC) screening strategies can decisively reduce both the incidence and mortality of this common malignancy, effectively eliminating longstanding